Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ARCA biopharma nets $8.1mm through FOPO

Executive Summary

Cardiovascular disease therapeutics developer ARCA biopharma Inc. netted $8.1mm through the FOPO of 5.1mm common shares for $1.70. Investors also received five-year warrants to buy another 1.3mm shares at $2.13. Dawson James Securities was the placement agent.
Deal Industry
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies